The UK Patient Support Programs (PSP) market is expected to grow from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of 7.9% for the year 2022-2030. Rising technological advancements as well as increased investments in the PSP segments by the pharmaceutical companies in the UK are the major drivers of the UK Patient Support Programs (PSP) market. The market is segmented by functionality outlook, therapeutic outlook, application outlook, and end user. Wren Healthcare, Alcura, and Atlantis Healthcare are some of the major operators in the UK Patient Support Programs (PSP) market.
The UK Patient Support Programs (PSP) market size is at around $xx Bn in 2022 and is projected to reach $xx Bn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The Department for Health and Social Care's budget provides funding for health services in England. In England, the Department of Health and Social Care anticipates spending $192.78 Bn in 2022–23 on these programs. National Health Service (NHS) England and NHS Improvement receive the majority of the Department's funds for use in paying for healthcare services. Compared to earlier forecasts, NHS England will receive a cash rise of $3.53 Bn in 2023–24 and 2024–25. Over the next two years, spending on NHS England will increase by 2% on average in real terms. Over the next two years, the whole Department of Health and Social Care budget will increase by 1.2% in real terms on average, which is significantly less than the historical average.
Patient Support Programs (PSPs) are maintained by several pharmaceutical companies to aid patients and/or medical professionals in better-managing disease and maximizing treatment. PSPs include a range of patient-directed interventions, from specific programs that attempt to educate patients and monitor patients on a particular medication to programs that specifically aim to improve illness management regardless of the patient's treatment. PSPs are now only recognized by organized systems in which a Marketing Authorization Holder (MAH) receives and gathers data regarding the use of its pharmaceuticals, according to a more limited definition of PSPs published by the European Medicines Agency (EMA). Alcura provides individualized medication adherence programs in the UK that can assist patients in getting the best results for their health. These programs include patient education and counseling provided by call centers or nurses.
Market Growth Drivers
In the UK, PSP use in healthcare is increasing along with other technological advancements. Patients can now get help and resources from the comfort of their homes because of digital technologies like smartphone apps and telehealth platforms. In order to differentiate their medications and enhance patient outcomes, pharmaceutical companies in the UK are investing more and more in inpatient assistance initiatives thereby resulting in the expansion of the UK PSP market.
Market Restraints
Despite the growing popularity of PSPs in the UK, there is still a lack of understanding about the benefits of these programs among patients and healthcare providers. Due to this, enrolling patients in the programs may be challenging, and healthcare practitioners may be less likely to implement PSPs.
S.No. | Patient Support Programs | Focus Area | Pharma Sponsor |
---|---|---|---|
1 | Patients and Healthcare Services Programs | Multiple Sclerosis | Biogen |
2 | Together Enbrel Patient Support Program | Chronic Inflammatory Diseases | Pfizer |
3 | Adveva program | Multiple Sclerosis | Merck |
4 | My Bones and Me | Osteoporosis | UCB |
5 | UCB Cares | Treatment Guidance | UCB |
6 | The You First program | Plaque Psoriasis | Novartis |
7 | Toujeo Coach | Diabetes | Sanofi |
8 | Connect 3600 | Eosinophilic Asthma | AstraZeneca |
9 | Together with GSK Oncology | Endometrial Cancer | GSK |
In the UK, the Association of the British Pharmaceutical Industry (ABPI) issued "Guidance Notes for patient safety and Pharmacovigilance in patient support programs" in 2011. The UK has industry codes specifically addressing PSPs and, in some cases, patient safety and data requirements or interactions with healthcare professionals (HCPs) and patients in connection with PSPs
Under ABPI guidance, PSPs typically include:
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Functionality Outlook
By Therapeutic area outlook
By Application outlook
By End-user
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?